Sulfasalazine therapy in patients with rheumatoid arthritis
Ichikawa, Y.; Takaya, M.
Ryumachi 27(1): 10-15
1987
ISSN/ISBN: 0300-9157 PMID: 2889275 Document Number: 295938
Document emailed within 1 workday
Related Documents
Mundo, A.; Pedone, V.; Lamanna, G.; Cervini, C. 1997: Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis La Clinica Terapeutica 148(1-2): 7-13Soejima, M.; Kawaguchi, Y.; Hara, M.; Kamatani, N. 2008: Prospective study of the association between NAT2 gene haplotypes and severe adverse events with sulfasalazine therapy in patients with rheumatoid arthritis Journal of Rheumatology 35(4): 724
Korthals-de Bos, I.; Van Tulder, M.; Boers, M.; Verhoeven, A.C.; Adèr, H.J.; Bibo, J.; Boonen, A.; Van Der Linden, S. 2004: Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone Journal of Rheumatology 31(9): 1709-1716
Dülgeroğlu, M. 1988: Sulfasalazine in juvenile rheumatoid arthritis Journal of Rheumatology 15(5): 881
López, R.; Cuquet, J.; Fitó, R.; Pujol, R. 1988: Sulfasalazine-induced megaloblastic anemia in rheumatoid arthritis Medicina Clinica 91(14): 559
Jajić, Z.; Jajić, I. 1998: Acute psychoses in patients with psoriatic arthritis during treatment with sulfasalazine Reumatizam 46(1): 43-44
Shmidt, E.I.; Belozerova, I.V.; Akhmedzhanov, F.M.; Soldatov, D.G. 2004: Structum therapy of patients with rheumatoid arthritis Terapevticheskii Arkhiv 76(11): 93-95
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Karimova, N.K. 1988: Concentrated sunlight in the therapy of patients with rheumatoid arthritis Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 5: 34-37
Jansen, T.L.Th.A.; Kroon, T.; Kamphuis, J.N. 2005: Pseudogout in 3 patients with presumed therapy-resistant rheumatoid arthritis Nederlands Tijdschrift Voor Geneeskunde 149(28): 1597-8; Author Reply 1598
Shakhbazova, S.S. 1988: Diluted baths with volcanic mud in the therapy of patients with rheumatoid arthritis Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 5: 31-33
Kapidzić-Basić, N.; Selesković, H.; Mulić, S. 2007: Effects of therapy on functional ability of patients with rheumatoid arthritis Medicinski Arhiv 61(3): 164-168
Baba, N.; Nomura, T.; Sakemi, T.; Uchida, M.; Watanabe, T. 1991: Membranous glomerulonephritis probably related to bucillamine therapy in two patients with rheumatoid arthritis Nihon Jinzo Gakkai Shi 33(6): 629-634
Trink, R.F. 1984: Evaluation of the effectiveness of health resort therapy of rheumatoid arthritis patients Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 40-42
Ilich-Stoianovich, O.; Nasonov, E.L.; Balabanova, R.M.; Chichasova, N.V. 1999: Clinical efficiency of infrared impulse laser therapy in patients with rheumatoid arthritis Klinicheskaia Meditsina 77(6): 20-23
Drosos, A.A.; Voulgari, P.V. 2001: Long-term efficacy and toxicity of a combination therapy in rheumatoid arthritis patients Clinical and Experimental Rheumatology 19(1): 111
Feuchtenberger, M.; Kleinert, S.; Scharbatke, E.-C.; Gnann, H.; Behrens, F.; Wittig, B.M.; Greger, G.; Tony, H.-P. 2015: The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 33(3): 321-329
Hassan, J.; Hanly, J.; Bresnihan, B.; Feighery, C.; Whelan, C.A. 1986: The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis Clinical and Experimental Immunology 63(3): 614-620
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Yu, C.; Li, M.; Duan, X.; Fang, Y.; Li, Q.; Wu, R.; Liu, S.; Wang, Y.; Wu, Z.; Shi, X.; Jiang, Z.; Wang, Y.; Hsieh, E.D.; Jin, S.; Jiang, N.; Wang, Q.; Zhao, Y.; Tian, X.; Zeng, X. 2018: Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis Clinical and Experimental Rheumatology 36(5): 836-840